Nucleated red blood cells: An update on the marker for fetal asphyxia,☆☆,

Presented at the Sixteenth Annual Meeting of the Society of Perinatal Obstetricians, Kamuela, Hawaii, February 4-10, 1996.
https://doi.org/10.1016/S0002-9378(96)80010-XGet rights and content

Abstract

OBJECTIVE: Our goal was to update our experience with nucleated red blood cells as a marker for fetal asphyxia and to determine whether a relationship exists between the presence of nucleated red blood cells and long-term neurologic impairment. STUDY DESIGN: Nucleated red blood cell data from 153 singleton term neurologically impaired neonates were compared with cord blood nucleated red blood cells of 83 term nonasphyxiated newborns. Newborns with anemia, intrauterine growth restriction, and maternal diabetes were excluded. The group of neurologically impaired neonates was separated into the following subgroups: group I, persistent nonreactive fetal heart rate pattern from admission to delivery (n = 69); group II, reactive fetal heart rate on admission followed by tachycardia with decelerations and absent variability (n = 47); group III, reactive fetal heart rate on admission followed by an acute prolonged deceleration (n = 37). The first and highest nucleated red blood cell value and the time of nucleated red blood cell disappearance were assessed. RESULTS: The mean number of initial nucleated red blood cells was significantly higher in the group of neurologically impaired neonates (30.3 ± 77.5, range 0 to 732 per 100 white blood cells) than in the control group (3.4 ± 3.0, range 0 to 12 per 100 white blood cells) (p < 0.000001). When the group of neurologically impaired neonates was separated on the basis of timing of the neurologic impairment, distinct nucleated red blood cell patterns were observed. Significant differences were obtained between each of the three groups of neurologically impaired neonates and the normal group, with respect to initial nucleated red blood cells (group I, 48.6 ± 106.9; group II, 11.4 ± 9.8; group III, 12.6 ± 13.4; p 0.000002). Maximum nucleated red blood cell values were higher in group I (mean 51.5 ± 108.9) than in groups II and III combined (mean 12.7 ± 11.9) (p = 0.0005). Group I also had a longer clearance time (119 ± 123 hours) than groups II and III combined (mean 59 ± 64 hours) (p < 0.001). CONCLUSION: Our ongoing study indicates that nucleated red blood cells identify the presence of fetal asphyxia. When fetal asphyxia is present, distinct nucleated red blood cell patterns are observed that relate to the timing of fetal injury. In general, intrapartum injuries are associated with lower nucleated red blood cell values. Thus our data continue to support the concept that nucleated red blood cell levels may assist in determining the timing of fetal neurologic injury. (Am J Obstet Gynecol 1996;175:843-6.)

Section snippets

MATERIAL AND METHODS

We used a case-control study design to compare normal nonasphyxiated newborns6 with neurologically impaired neonates in whom hypoxic ischemic encephalopathy had been diagnosed in the neonatal period.8 Mixed umbilical cord blood samples obtained at birth were analyzed from normal newborns who were delivered at a community hospital and met the following entry criteria: appropriate-for-gestational-age neonate at ≥37 weeks' gestation, birth weight >2800 gm, Apgar score ≥7 at both 1 and 5 minutes,

RESULTS

During the course of the investigation, 83 normal, nonasphyxiated newborns underwent umbilical cord blood analysis to determine the nucleated red blood cell count at birth.6 Of 269 term live-born neurologically impaired neonates in the registry, 153 (57%) met selection criteria for the study. The reasons for exclusion are illustrated in Table I.

The distribution of nucleated red blood cells for the normal and asphyxial injury population is illustrated in Fig. 1. There the normal nonasphyxiated

COMMENT

The current investigation supports our prior work on the role of nucleated red blood cells as a potential marker for fetal asphyxia.6 Regardless of the fetal pathophysiologic mechanism responsible for fetal injury, the nucleated red blood cell counts were significantly higher among asphyxiated neonates than for a group of normal nonasphyxiated newborns. The time required to produce an elevation in nucleated red blood cell count remains unknown but appears to be relatively short in the light of

References (10)

There are more references available in the full text version of this article.

Cited by (128)

  • Haematological issues in neonates with neonatal encephalopathy treated with hypothermia

    2021, Seminars in Fetal and Neonatal Medicine
    Citation Excerpt :

    nRBCs in cord blood are predictive of NE in case-control studies with both acute and chronic antepartum fetal hypoxia and ischemia [11]. Korst et al. suggested that the nRBCs could be indicative of the timing of the hypoxic-ischemic event with higher levels of nRBCs reported in neonates who had abnormal fetal heart rate tracings prior to labour (n = 153), compared to those neonates who had intrapartum changes in fetal heart rate tracing (n = 83) [12]. Ghosh et al. found elevated nRBCs in umbilical blood also correlated with poor early neonatal outcome [11].

  • FIRS: Neonatal considerations

    2020, Seminars in Fetal and Neonatal Medicine
  • Nucleated red blood cell counts: An early predictor of brain injury and 2-year outcome in neonates with hypoxic-ischemic encephalopathy in the era of cooling-based treatment

    2014, Brain and Development
    Citation Excerpt :

    However, there has been no reliable method to differentiate poor neurological prognosis in the first 6 hours after birth [2,3]. Factors such as pH, base deficit, and lactate levels at birth are markers for acute asphyxia, but they do not provide a good estimate of the chronicity of the acid-base disturbance, which is an important antecedent of irreversible brain damage [9,21]. In contrast, because of the time taken for the process of NRBC elevation after hypoxia, an increased umbilical/peripheral NRBC count reflects both the chronicity and severity of the acid-base disturbance and may be an important early predictor of poor neurodevelopment [12,16,21].

View all citing articles on Scopus

From the Department of Obstetrics and Gynecology, The Perinatal Center, Pomona Valley Hospital Medical Center; the Department of Obstetrics and Gynecology, Cha Women's Hospital of Seoul; the Department of Neonatology, Queen of the Valley Hospital; and the Department of Pediatrics, University of California, Irvine, School of Medicine.

☆☆

Reprint requests: Jeffrey P. Phelan, MD, Suite 200, 1030 S. Arroyo Parkway, Pasadena, CA 91105.

0002-9378/96 $5.00 + 0 6/6/75614

View full text